These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28964452)

  • 1. A Systematic Review of the Techniques Used to Value Temporary Health States.
    Ogwulu CB; Jackson LJ; Kinghorn P; Roberts TE
    Value Health; 2017 Sep; 20(8):1180-1197. PubMed ID: 28964452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for measuring temporary health States for cost-utility analyses.
    Wright DR; Wittenberg E; Swan JS; Miksad RA; Prosser LA
    Pharmacoeconomics; 2009; 27(9):713-23. PubMed ID: 19757865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valuing the health states associated with Chlamydia trachomatis infections and their sequelae: a systematic review of economic evaluations and primary studies.
    Jackson LJ; Auguste P; Low N; Roberts TE
    Value Health; 2014; 17(1):116-30. PubMed ID: 24438725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Auctions: a Valuation Experiment (HAVE) study protocol.
    Kularatna S; Petrie D; Scuffham PA; Byrnes J
    BMJ Open; 2016 Apr; 6(4):e009081. PubMed ID: 27056589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in Valuing Temporary Health States for Economic Evaluation: A Review of Empirical Applications of the Chained Time Trade-Off Method.
    Stoniute J; Mott DJ; Shen J
    Value Health; 2018 May; 21(5):605-611. PubMed ID: 29753359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-Analysis.
    Mohiuddin S; Payne K
    Med Decis Making; 2014 Jul; 34(5):666-85. PubMed ID: 24695961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health status utilities in pediatrics: a systematic review of acute lymphoblastic leukemia.
    van Litsenburg RR; Kunst A; Huisman J; Ket JC; Kaspers GJ; Gemke RJ
    Med Decis Making; 2014 Jan; 34(1):21-32. PubMed ID: 23886678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter.
    Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
    Value Health; 2018 Apr; 21(4):456-461. PubMed ID: 29680103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health state valuation in low- and middle-income countries: a systematic review of the literature.
    Kularatna S; Whitty JA; Johnson NW; Scuffham PA
    Value Health; 2013; 16(6):1091-9. PubMed ID: 24041360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of 3 valuation methods for temporary health states in patients treated with oral anticoagulants.
    Locadia M; Stalmeier PF; Oort FJ; Prins MH; Sprangers MA; Bossuyt PM
    Med Decis Making; 2004; 24(6):625-33. PubMed ID: 15534343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Income effects of reduced health and health effects of reduced income: implications for health-state valuation.
    Sculpher MJ; O'Brien BJ
    Med Decis Making; 2000; 20(2):207-15. PubMed ID: 10772358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review.
    Herdman M; Cole A; Hoyle CK; Coles V; Carroll S; Devlin N
    Value Health; 2016; 19(2):255-66. PubMed ID: 27021761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The measurement of contingent valuation for health economics.
    Bayoumi AM
    Pharmacoeconomics; 2004; 22(11):691-700. PubMed ID: 15250748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Valuation of health-related quality of life and utilities in health economics].
    Greiner W; Klose K
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(2-3):120-5. PubMed ID: 24780709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the UK NICE "reference case" influencing the practice of pediatric quality-adjusted life-year measurement within economic evaluations?
    Adlard N; Kinghorn P; Frew E
    Value Health; 2014 Jun; 17(4):454-61. PubMed ID: 24969007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the use of health status measures in economic evaluation.
    Brazier J; Deverill M; Green C
    J Health Serv Res Policy; 1999 Jul; 4(3):174-84. PubMed ID: 10538884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?
    Boye KS; Matza LS; Feeny DH; Johnston JA; Bowman L; Jordan JB
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):437-50. PubMed ID: 24832003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.